Derniers manuscrits de l'équipe
-
-
Cyrille Féray, Loic Campion, Philippe Mathurin, Isabelle Archambreaud, Xavier Mirabel, et al.. TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial. JHEP Reports Innovation in Hepatology, 2023, 5 (4), pp.100689. ⟨10.1016/j.jhepr.2023.100689⟩. ⟨hal-04044132⟩
-
Natascha Roehlen, Marion Muller, Zeina Nehme, Emilie Crouchet, Frank Jühling, et al.. Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment. Journal of Hepatology, 2023, 78 (2), pp.343-355. ⟨10.1016/j.jhep.2022.10.011⟩. ⟨hal-04017104⟩
-
Lena Allweiss, Barbara Testoni, Mei Yu, Julie Lucifora, Chunkyu Ko, et al.. Quantification of the Hepatitis B Virus cccDNA: Evidence-based guidelines for 2 monitoring the key obstacle of HBV cure 3 Short Title: cccDNA quantification harmonization 4 5. Gut, 2023, pp.gutjnl-2022-328380. ⟨10.1136/gutjnl-2022-328380⟩. ⟨hal-03992742⟩
-
-
Benoît Allignet, Pierre Pradat, Françoise Mornex, Floriane Izarn, Agnès Rode, et al.. Surgical resection versus transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma. Strahlentherapie und Onkologie, 2023, 199 (3), pp.293-303. ⟨10.1007/s00066-022-02022-0⟩. ⟨hal-04156031⟩